Abstract Background: Immune-mediated comorbidities are increasingly recognized in people with multiple sclerosis (PwMS), but their frequency, recorded diagnostic sequence, and clinical relevance remain incompletely characterized. We aimed to characterize their co-occurrence with MS, diagnoses following MS, associations with subsequently diagnosed MS, and relationships with MS clinical outcomes. Methods: We conducted a scoping review guided by the PRISMA-ScR checklist.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile